Delivery Order SPE2DB22D3004-SPE2DB25FQ77B
- Not listed
- The Defense Logistics Agency (DLA) awarded a $13,798.00 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $20,229.68 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $2,759.60 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract is not subject to any set-aside designation and is scheduled for completion by September 10, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.80 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on March 5, 2025, with completion expected by March 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open procurement procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,080.32. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a $27,237.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery is designated for performance at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,796.14 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies vaccines, medications, medical devices, and...
- The Defense Logistics Agency awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 9, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $68,990 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical delivery to be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,069.70 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on July 21, 2025, and the product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ77BDelivery Order
The Defense Logistics Agency (DLA) awarded a $19,636.68 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems. The contract will be performed at the company's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 9/17/25 |